Swine Vaccines Market Size, Share, Growth, and Industry Analysis, By Type (CSF Vaccines, FMD Vaccines, Porcine Circovirus Vaccines, PRRS Vaccines, Others), By Application (Government Tender, Market Sales) and Regional Insights and Forecast to 2034

•   
•   
  

  Request a Free sample to learn more about this report

    

SWINE VACCINES MARKET OVERVIEW

The global swine vaccines market size was USD 1.55 billion in 2025 and is projected to touch USD 2.22 billion by 2034, exhibiting a CAGR of 4.1% during the forecast period.

The global swine vaccines market is concerned with the advancement and sale of inoculations that keep pigs immune to the infectious diseases like porcine reproductive and respiratory syndrome (PRRS), swine influenza, and classical swine fever. The pork industry will greatly need these vaccines to ensure food security, enhancement in productivity and supporting the health of herds. The growth of the market is pushed by the growing interest in the health of the animals, the rising level of demand in the high-quality pork, and the growing risk of the zoonotic diseases. The use of technological innovations of recombinant vaccines and DNA-based vaccines is improving efficacy and safety. Also, favorable government programs and the increasing commercial pig farming activities are driving the world swine vaccine demand.

COVID-19 IMPACT

Swine Vaccines Market Had a Negative Effect Due to Disrupting Production, Supply Chains, and Veterinary Healthcare Services Worldwide During COVID-19 Pandemic

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic negatively affected the swine vaccines market share in large magnitude as it interfered with all principles of production, supply chain, and veterinary healthcare delivery across the globe. Lockdown and travel restrictions canceled the production of vaccines, their delivery, and on-field vaccination. Numerous swine farms suffered an interruption of the regular immunization to compound the exposure to diseases and loss of earnings. Also, the shortage of personnel, lack of access to professional medical staff, and the redistribution of resources to human health slowed down the work in the market. The pandemic also had a toll on the international trade and consumption of pork products reducing the level of investment made by farmers in preventive healthcare. The market has slowly recovered after the pandemic, but the disruptions in the short term demonstrated the importance of animal health systems that will be resilient.

LATEST TRENDS

Rising Adoption of Advanced Recombinant and DNA-Based Vaccines Drives Market Growth

One of the latest trends in the swine vaccines market is the increased use of recombinant and DNA-based vaccines to prevent and protect against diseases as well as to prevent bioterrorism. These are more improved vaccines that confer better and long-lasting protection and eliminates the risks of having live or inactivated pathogens. Recombinant technologies provide the possibilities of creating multivalent vaccines that target many diseases of swine at the same time reducing vaccination frequency and costs. Also, DNA-based vaccines can be easily adapted to new strains of the virus that can offer greater efficiency in disease control. With increased advances in both molecular biology and immunology, these new platforms of vaccines are changing the current way swine health is managed guarantee safer herds and the sustainability of the world pork industry.

•   
•   
  

  Request a Free sample to learn more about this report

    

SWINE VACCINES MARKET SEGMENTATION

By Type

Based on type, the global market can be categorized CSF vaccines, FMD vaccines, porcine circovirus vaccines, PRRS vaccines, others

• CSF Vaccines: Classical Swine Fever is a dangerous viral disease that leads to high mortality resulting in hemorrhages and fever when pigs are exposed to Classical Swine Fever caused by CSF vaccines. These types of vaccines that are live attenuated and inactivated are critical to disease eradication programs. Pig research aims to stop outbreaks and encourage pork products trade worldwide with the help of vaccination.

• FMD Vaccines: FMD vaccines protect pigs against the Foot-and-Mouth Disease, which is a viral disease that causes a severe infection in animals with cloven hoofs. They also play a crucial role in managing outbreaks with the capacity to bring down livestock economies. Frequent immunizations ensure that there is herd immunity and low production losses.

• Porcine Circovirus Vaccines: These are progesterone circovirus type 2 (PCV2) vaccines that cause post-weaning multisystemic wasting syndrome (PMWS). Vaccination enhances growth, decreases mortality, and increases productivity of pigs. In commercial pig farms the world over, a preventive measure against PCV2 vaccines is the new standard.

• PRRS Vaccines: PRRS vaccines prevent respiratory disease in piglets and reproductive failure in sows, which are caused by a highly contagious virus. They both utilize modified live and killed vaccine to control the severity of infections. They are very important in swine herd health and economic stability.

• Others: Such diseases as swine influenza, Mycoplasma hypermania and parvovirus are included in this category. By means of these vaccines, overall herd immunity is increased, and secondary infections are prevented. They are increasingly used because of the increased awareness on comprehensive disease prevention and farm biosecurity practices.

By Application

Based on by application, the global market can be categorized into government tender, market sales

• Government Tender: The application in government tenders deals with the purchase and supply of vaccines via the public health and the national disease control programs. These vaccines are also distributed in large quantities to prevent and eliminate major swine diseases in the national level. These programs are essential in developing areas whereby the governments are central in the management of livestock health.

• Market Sales: Commercial sale of swine vaccines to distributors, veterinary clinics and farms can be referred to as market sales. This segment is led by increased interest in animal health and end of commercial pig farming preventive healthcare. It provides the choice of vaccines, which fosters competition and innovation of unstable manufacturers.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factors

Rising Prevalence of Swine Diseases Boost the Market

One driving factor in the swine vaccines market growth is the increasing number of infectious diseases being challenged by Porcine Reproductive and Respiratory Syndrome (PRRS), Classical Swine Fever (CSF), and the Foot-and-Mouth Disease (FMD). These ailments lead to a big economic loss in terms of lost productivity, death, and trade restrictions. The increased prevalence of pig farming in the world is increasing the rate of diseases transmissions and thereby the need to use preventive vaccination programs. Biosecurity, mass immunization programs are being enforced by governments and livestock associations to ensure the safety of the health of herds. This makes the worldwide swine vaccines market continue to be in the growth profile as there is an increasing need to have effective and wide spectrum vaccines.

Increasing Demand for Safe and High-Quality Pork Products Expand the Market

The swine vaccines market is being pushed by the increase in consumption of pork and demand by consumers towards safe, disease-free meat across the world. The requirements of consumers and importers in terms of animal welfare and food safety are also increasing and consequently farmers are considering the use of preventive vaccination as a measure of biosecurity control. Pigs that are vaccinated experience better health, product high feed to weight ratios, and quality meat production to materialize profitability to the producer. In addition, emergency global trade rules have come with disease-free status of the exported pork production which further promotes vaccination. With heightening sensitivity of the perception on risks of zoonotic diseases and pathogenic bacteria into food, the application of highly developed vaccine becomes critical to the assurance of the integrity of the supply chain and the compliance with the global standard of food safety.

Restraining Factor

High Cost of Vaccine Development and Cold Chain Maintenance Impede Market Growth

One of the limitations of the vaccines market of swine’s is the swine vaccine is costly to establish and maintain the cold chain logistics. The cost of developing effective vaccines is high because it involves a lot of testing, regulatory approvals, and other biotechnological processes that raise the costs of production. Also, cold chain storage and transportation should be done correctly to ensure the efficacy of the vaccines particularly in remote or tropical areas. This cost can usually be overwhelming to small farmers in developing nations making broad acceptance of vaccines difficult. Additionally, the unstable prices of raw materials and insufficient financing of veterinary medical care programs also contribute to the cost pressure creating a strong threat to access to markets and their expansion opportunities.

Advancements in Biotechnology and Novel Vaccine Platforms Create Opportunity for The Product in The Market

Opportunity

Biotechnology has a great potential on the swine vaccines market since the creation of next-generation vaccines can be created. Other improvements to existing vaccines include recombinant, subunit, and DNA-based vaccination which are safer, have increased immunogenicity, and are quicker to modify against new viral strains. They allow the development of multi-valent vaccines which can prevent multiple diseases at one dose which saves money and increases adherence.

Further, organizations of research, animal health companies, and governments are also partnering to encourage the speed of innovation. Since the industry also aims to maintain the accuracy of livestock health and disease prevention, biotechnology is likely to transform the world swine vaccines market, developing a higher level of protection against the swine, and subsequent growth of the market.

Lack of Disease Surveillance and Diagnostic Infrastructure Could Be a Potential Challenge for Consumers

Challenge

One of the greatest problems facing the swine vaccines market is the absence of proper disease surveillance systems and diagnostic infrastructure especially in developing areas. Swine diseases are very dangerous when detected later and proper veterinary facilities or diagnostic equipment may not be available in many farms. Lack of consistent data collection and that of outbreaks prevents proper disease control and planning of vaccinations. In some countries, this is exacerbated by the lack of veterinary personnel and the poor regulatory systems.

In the absence of powerful surveillance and monitoring, the implementation of vaccines turns into a response strategy as opposed to a preventive measure, which will lower effectiveness. The reinforcement of the diagnostic networks and the farm-level monitoring of health conditions is the key to getting past this obstacle and achieve sustainable disease management.

•   
•   
  Request a Free sample to learn more about this report

    

SWINE VACCINES MARKET REGIONAL INSIGHTS

• North America

The United States swine vaccines market has a very high share in North America because of the developed veterinary healthcare systems, favorable regulatory systems, and superior pork production in the U.S and Canada. The region focuses on preventive healthcare to manage such diseases as PRRS and swine flu with the help of vaccination programs financed by the government. The process of constant investments in R&D by major participants in the field and the association of livestock producers with vaccine manufacturers enhance the evolution of the market. In addition to this, there is an introduction of new technologies in the form of recombinant and DNA based vaccines, which increases the efficiency in the control of the disease. The concentration of food, biosecurity, and animal welfare in the region contributes further to the push of the effective and quality swine vaccines.

• Europe

The European region dominates the world swine vaccines market because the region has stringent animal health guidelines, standards of food safety, and greater importance on disease prevention. Other large pork producers like Germany, France, Denmark, and Key Netherlands are acquiring inclusive vaccination programs. European Union empowers the eradication programs of diseases, such as Classical Swine Fever surveillance and PRRS. The market is additionally supported by the continued research on next-generation and multivalent vaccines. Also, partnerships between civic entities and animal healthcare providers are the force of innovations. The emphasis on sustainable livestock husbandry in Europe as well as reducing the use of antibiotics is still raising the uptake of advanced vaccines.

• Asia

Asia-Pacific is the fastest expanding industry in the swine immunization industry, and this is attributed to high pig counts in China, India, Vietnam, and the Philippines. The successful vaccination programs have been increased by frequent occurrences of swine diseases like the African Swine Fever (ASF) and PRRS. Governments are putting a lot of resources in disease surveillance, veterinary facilities, and biosecurity to stabilize production of swine. There is also increased adoption of vaccines due to the growing consumption of meat and increased awareness as regards animal health. Both local and foreign manufacturers are increasing operations to respond to the demands in the region. As Asia-Pacific has long been a promising swine vaccine market since the distribution of the vaccines and management practices of the farms continue to be improved, the region is now becoming one of the most important ones.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market Through Innovation and Market Expansion

The key industry players in swine vaccines market are Zoetis Inc., Merck Animal Health, Boehringer Ingelheim Animal Health GmbH, Ceva Sante Animale, Elanco Animal Health Incorporated, HIPRA S.A, Phibro Animal Health Corporation and Virbac S.A. These companies are geared towards producing new vaccines to deal with leading swine illnesses like PRRS, CSF and FMD. They spend a lot of money on the research and development, biotechnology, and partnership with veterinary schools to increase the effectiveness of vaccines and their distribution. These players are trying to enhance herd immunity, food safety, and solid market presence worldwide through technological innovations and international collaborations and product diversification.

List Of Top Swine Vaccines Market Companies

• Merck (U.S.)
• Boehringer Ingelheim (Germany)
• Jinyu Bio-Technology (China)
• CAHIC (China)

KEY INDUSTRY DEVELOPMENT

September 2025: The first swine vaccine containing PCV2a and PCV2d antigens was introduced in the United States by Boehringer Ingelheim Animal Health as INGELVAC CIRCOFLEX AD. This technology improves safeguarding against the new strains of the Porcine Circovirus and streamlines the process of vaccination in the producers.

REPORT COVERAGE

The market of swine vaccines will be stable and grow due to the increased rates of infectious diseases in swine, greater consumption of safe pork products and development of new vaccine technologies. Use of recombinant, DNA based, and multivalent vaccines is enhancing control of disease and herd productivity in the world. Market is further expanding rapidly due to government efforts, stringent animal health requirements and increasing awareness on biosecurity. Nonetheless, there are difficulties in the cost of creating vaccines and a lack of disease surveillance in developing countries. These limitations notwithstanding, sustainable development of the swine immunization industry is projected by consistent investment in research and development, digitalization of the animal healthcare industry, and international partnerships among prominent industry participants.